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Figure S4. Fluorescence intensity at 560 nm of a 30 µM solution of ligand 8 (yellow bars) and 
complex 14 (green bars) in the presence or absence of LMW-PTP (Enz) and 1mM EDTA in Tris buffer 
containing 1mM DTT. Reading was taken after 5 minutes incubation at room temperature. Intensity 
is recorded ±standard deviation of triplicate repeats.  
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Figure S3. Fluorescence spectra of 8, 14, and 15 at 30µM in 100 mM Tris buffer 
containing 1 mM DTT. Readings were taken using a Varian fluorescence spectrometer 
in a 96-well plate with excitation of 340 nm and emission recorded from 400-650 nm.  
  
Figure S5. Fluorescence intensity at 560 nm of a 30 µM solution of ligand 13 (yellow bars) and 
complex 15 (green bars) in the presence or absence of LMW-PTP (Enz) and 1mM EDTA in Tris buffer 
containing 1mM DTT. Reading was taken after 2 hours incubation at room temperature. Intensity is 
recorded ±standard deviation of triplicate repeats.  
 
 
  
Figure S6. Activity of LMW-PTP in the presence of increasing amounts of ligands 8 and 13. LMW-PTP 
activity was measured using the OMFP method (see Experimental Details – Phosphatase inhibition 
assays). The ligand solutions (prepared from 10 mM stock solution in DMSO and further diluted in 
water containing 1% DMSO to the required concentrations) were incubated with the enzyme in the 
buffer (100 mM Tris, pH = 7.4, containing 1 mM DTT) for 10 minutes at room temperature before 
reaction was initiated by addition of OMFP. Reading was taken over 30 minutes at 60 s intervals. 
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Figure S7. Activity of VHR in the presence of increasing amounts of ligands 8 and 13. VHR activity 
was measured using the OMFP method (see Experimental Details – Phosphatase inhibition assays). 
The ligand solutions (prepared from 10 mM stock solution in DMSO and further diluted in water 
containing 1% DMSO to the required concentrations) were incubated with the enzyme in the buffer 
(100 mM Tris, pH = 7.4, containing 1 mM DTT) for 10 minutes at room temperature before reaction 
was initiated by addition of OMFP. Reading was taken over 30 minutes at 60 s intervals. 
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